Business Context and Reporting Period
This Form 8-K was filed by Synaptogenix, Inc. (SNPX) on July 13, 2021. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in New York. The filing reports on a specific corporate governance event regarding equity compensation approved by the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the approval of a one-time grant of restricted stock units (RSUs) to directors and management.
Material Changes and Events
The primary material event is the approval of a one-time RSU grant on July 13, 2021, recognizing efforts related to the company's spin-off, up-listing to The Nasdaq Capital Market, and a private placement financing completed in June 2021. The total grant consists of 485,000 RSUs distributed as follows:
- Joshua N. Silverman: 90,000 RSUs
- Daniel Alkon, M.D.: 80,000 RSUs
- Alan J. Tuchman, M.D.: 60,000 RSUs
- Robert Weinstein: 60,000 RSUs
- William S. Singer: 60,000 RSUs
- Bruce T. Bernstein: 50,000 RSUs
- Jonathan L. Schechter: 45,000 RSUs
- George Perry, Ph.D.: 40,000 RSUs
The RSUs vest 50% on the six-month anniversary of the grant date and the remaining 50% on the one-year anniversary.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, financial outlook, or specific risk factors beyond the standard terms of the equity incentive plan. The grants are subject to the terms of the Company's 2020 Equity Incentive Plan and the form of restricted stock unit agreement approved by the Board.
Investor Verification Checklist
- Verify the vesting schedule and specific terms in the 2020 Equity Incentive Plan referenced in the filing.
- Confirm the impact of the June 2021 private placement financing on the company's capital structure.
- Review the upcoming Form 10-Q for the quarter ended June 30, 2021, which will include the RSU agreement as an exhibit.
- Monitor the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.